Cubist Pharmaceuticals Issues $800M of Convertible Senior Notes
September 10, 2013 at 16:01 PM EDT
Cubist Pharmaceuticals (NASDAQ: CBST ) today announced the closing of its previously announced offering of $800 million aggregate principal amount of convertible senior unsecured notes in two series, with one series maturing on September 1, 2018 (the 2018 notes) and the other series maturing on September 1, 2020 (the
